Winnon v. Lozano ( 2023 )

UNITED STATES DISTRICT COURT
FOR THE DISTRICT OF COLUMBIA
UNITED STATES & STATE OF TEXAS )
ex rel. TERRI R. WINNON )
)
Plaintiffs, )
)
~ ) Civil Case No. 17-2433 (RJL)
)
RAMIRO LOZANO, etal., )
)
Defendants. )
k--
MEMORANDUM OPINION
(August 'f_, 2023) [Dkt. #68]
Relater Terri R. Winnon ("Winnon" or "Relater") brought suit on behalf of the United
States and the State of Texas under the qui tam provisions of the False Claims Act, 31
U.S.C. § 3729, et seq. ("False Claims Act" or "FCA"), and the Texas Medicaid Fraud
Prevention Law, TEX. HUM. RES. CODE ANN.§ 36.011, et seq. ("TMFPL"). See Relator's
Second Am. Compl. ("SAC") [Dkt. #23] ,i 1. The action is brought against seventeen
defendants who have been organized into three groups of defendants. This Memorandum
Opinion addresses only the Relater's claims as it relates to one of the groups comprised
of six physicians - Miguel A. Molinas, Diana Carubba, Ronalda Factoriza, Francis
Gumbel, Paul A. Lenz, and Javier A. Jover (collectively the "Defendant Physicians"). 1
1 The two other groups of defendants are: first, RehabCare Group East, LLC ("RehabCare"); and second, eight
Skilled Nursing Facility ("SNF") entities ("Defendant Facilities"), Ramiro Lozano ("Lozano"), and Jay W.
Balentine ("Balentine"). The eight Defendant Facilities include: RJ Meridian Care Alta Vista, LLC; RJ Meridian
Care of Alice, LTD; RJ Meridian Care of Galveston, LLC; RJ Meridian Care of Hebbronville, LTD; RJ Meridian
Care of San Antonio, LTD; RJ Meridian Care of San Antonio III, LLC; Spanish Meadows of Katy, LTD; and
Empire Spanish Meadows, LTD.
1
Relator alleges the defendants knowingly submitted, or caused to be submitted, false
claims to government health care programs, including Medicare and the Texas Medicaid
program, and knowingly offered, paid, solicited and/or accepted remunerations in
exchange for medical referrals in violation of federal and state laws. Id. at 1 2. The
Defendant Physicians moved to dismiss Relator's SAC. For the following reasons, the
Defendant Physicians' Motion to Dismiss is hereby GRANTED. 2
I. BACKGROUND
a. Procedural History
Relator was the Executive Assistant and then Controller for Lozano who, along with
Balentine, owned, controlled, and operated a number of health care facilities throughout
Texas from January 2009 through at least 2016. Id. at 113, 12. The health care facilities
included SNFs, assisted living facilities, and independent living facilities. Id. at 1 3.
Lozano and Balentine owned, controlled, and operated these health care facilities
through the eight Defendant Facilities. Id. The Defendant Facilities were enrolled as
Medicare and Texas Medicaid providers during the relevant time period. Id.
After a period of time working for Lozano, Winnon began to notice anomalies with
the companies' finances and became concerned about certain practices by Lozano,
2
The Court declines to exercise supplemental (or "pendant") jurisdiction over remaining state claims. See 28 U.S.C.
§ 1367; Carnegie-Mellon University v. Cohill, 484 U.S. 343, 350 n.7 (1998) (finding that when all federal claims are
eliminated before trial, courts may "declin[ e] to exercise jurisdiction over the remaining state-law claims.");
Edmondson & Gallagher v. Alban Towers Tenants Ass 'n, 48 F.3d 1260, 1267 (D.C. Cir.1995).
2
Balentine, and the Defendant Facilities. Id. at ,r 11. After raising such concerns to Lozano
over a period of time, she was terminated. Id.On March 16, 2016, and prior to the November 2017 filing of her complaint in this
case, Relator entered into a separation agreement with Spanish Meadows - Meridian
Care Companies. See Separation of Employment Agreement, Release of Claims &
Confidentiality Agreement [Dkt. # 70-1] ("Release"); SAC. 3 The Release provided, in
relevant part:
Terri Winnon ... RELEASES, ACQUITS, AND FOREVER DISCHARGES ...
Spanish Meadows - Meridian Care and all subsidiaries, affiliates, related entities,
owners, directors, officers, members, management companies and/or parents
thereof, including but not limited to Ramiro G. Lozano and Jay Balentine, and all
partnerships, companies, and corporations owned in whole or part by any of the
foregoing persons or entities, and all partnerships and corporations related or
affiliated therewith or which may become related or affiliated thererto in the
future, and the successors, assigns, representatives, employees, agents, directors
and officers of the forgoing and their affiliates, directors, officers, agents, insurers,
employees, servants, successors, and assigns of the forgoing ("the "Released
Parties") from any and all claims, causes of action, suits, demands and liabilities
(collectively "Claims") known or unknown, foreseen or unforeseen ... including
3 When faced with subject matter jurisdiction questions in a motion to dismiss, "it is well established in this Circuit
that a court is not limited to the allegations in the complaint, but may also consider material outside of the pleadings
in its effort to determine whether the court has jurisdiction in the case." U.S. ex rel. El-Amin, 2007 WL 1302597, at
*2 (citing Alliance for Democracy et al., v. Federal Election Comm 'n, 362 F.Supp.2d 138, 142 (D.D.C. 2005)).
3
but not limited to all claims under ... the Federal False claims Act, 31 U.S.C. §
3730(h) ...
Id. at 3-4.
Winnon filed this action in November 2017, asserting claims for violations of the
FCA and the TMFPL. See SAC. The United States sought and received from the Court
several extensions of time to conduct its own investigation of the facts and to consider
whether it would intervene. In February 2022, the United States and the State of Texas
noticed their election to decline intervention,4 and shortly thereafter the Court unsealed
relevant portions of the record and directed for the Complaint to be served upon all
defendants. 5 In July 2022, the three groups of defendants filed separate Motions to
dismiss. 6 In March 2023, the Court granted the Defendants' Motion to Stay Discovery.
Minute Order (Mar. 30, 2023).
b. Summary of Relator's Allegations
As discussed in more detail below, Winnon alleges in her SAC that Winnon, Lozano,
and the Defendant Facilities paid remunerations to a number of referral sources through
medical directorships and gifts. See SAC at ,15. Winnon alleges that the six Defendant
Physicians received unlawful remuneration from Empire Spanish Meadows, LTD in
4
See Notice of Election to Decline Intervention by United States of America [Dkt. #28] ("Gov't Notice to Decline
Intervention").
5 See Order (Feb. 10, 2022) [Dkt. #29].
6 Def. Miguel A. Molinas, Diana Carubba, Ronalda Factoriza, Francis Gumbel, Paul A. Lenz, and Javier A. Jover's
Mot. to Dismiss Relator's Second Am. Compl. [Dkt. #68] ("Def. Physicians' MTD"); Def. RehabCare Group East,
LLC's Mot. to Dismiss Relator's Second Am. Compl. [Dkt. #69]; SNF Def. 's Mot. to Dismiss Second Am. Compl.
[Dkt. #70] ("SNFs' MTD").
4
order to induce referrals of Medicare and Medicaid patients in violation of the Anti-
Kickback Statute, 42 U.S.C. § 1320a-7b(b) ("AKS"), the Physician Self-Referral Law, 42
U.S.C. § 1395nn ("Stark Law"), the TMFPL, the Texas Human Resource Code - Medical
Assistance Program, TEX. HUM. RES. CODE ANN. § 32.039(b) ("MAP"), and the Texas
Patient Solicitation Act, TEX. 0cc. CODE ANN.§ 102.011, et seq. ("TPSA"). Id. at ,r 6.
Specifically, Winnon alleges that the Defendant Facilities paid certain physicians,
including the six Defendant Physicians, as medical directors in an effort to illegally
induce patient referrals to the SNFs. Id. at ,r,r 96-98. She also alleges that one of the
Defendant Facilities, Empire Spanish Meadows, provided remunerations (in the form of
alcohol, meals, etc.) to discharge planners and doctors, including the six Defendant
Physicians, as evidenced by Empire Spanish Meadows' own account records. Id. at ,r,r
109-10.
II. ANALYSIS
The Defendant Physicians argue in their Motion to Dismiss that the Relator's SAC
should be dismissed because, iter alia, 7 Relator's severance agreement bars her action and
Relator fails to plead fraud with adequate particularity, as required by Rule 9(b ).
In addition, the Defendant Physicians contend that the release signed by the Relator
bars her from bringing any action against the Defendant Physicians and that this Court
7
Defendant Physicians also argue in their Motion to Dismiss that Relator fails to state a claim for relief under Rule
12(b)(6), Relator's conspiracy claim is conclusory and must be dismissed, and that Relator's state law claims should
be dismissed.
5
does not have subject matter jurisdiction over Relator's claims. 8 Relator, however, argues
that the release should not be enforced, inter alia, because it is invalid and unenforceable
for public policy reasons. 9 Unfortunately for the Relator, the Court finds that while the
release does not bar Relator from bringing this action against the Defendant Physicians
the Relator doesn't plead fraud against the Defendant Physicians with adequate
particularity; How so?
"Under Rule 12(b)(l) of the Federal Rules of Civil Procedure, which governs motions
to dismiss for lack of subject matter jurisdiction, 'the plaintiff bears the burden of
persuasion to establish subject matter jurisdiction by a preponderance of the
evidence."' Alliance for Democracy v. FEC, 362 F.Supp.2d at 141-42 (quoting Pitney
Bowes, Inc. v. United States Postal Serv., 27 F.Supp.2d 15, 19 (D.D.C.1998)). "For
purposes of ruling on a motion to dismiss for want of standing, both the trial and
reviewing courts must accept as true all material allegations of the complaint, and must
construe the complaint in favor of the complaining party." Warth v. Seldin, 422 U.S. 490,
501 (1975) (citing Jenkins v. McKeithen, 395 U.S. 411, 421-22 (1969)). "Additionally, in
deciding a Rule 12(b)(l) motion, it is well established in this Circuit that a court is not
limited to the allegations in the complaint, but may also consider material outside of the
pleadings in its effort to determine whether the court has jurisdiction in the
case." Alliance for Democracy, 362 F.Supp.2d at 142 (citing Equal Employment
8 The Defendant Physicians' Motion to Dismiss, Def. Physicians' MTD at 16-17, incorporates by reference the
arguments made by Lozano, Balentine, and the Defendant Facilities, SNFs' MTD at 38-42.
9 Relator' s Resp. to Defs. Miguel A. Molinas, Diana Carubba, Ronalda Factoriza, Francis Gumbel, Paul A. Lenz,
and Javier A. Jover's Mot. to Dismiss Relator's Second Am. Comp!. at 9-16 [Dkt. #75] ("Relator's Resp. to Def.
Physician's MTD.") .
6
Opportunity Comm'n v. St. Francis Xavier Parochial Sch., 326 U.S.App. D.C. 67, 70-71,
117 F .3d 621, 624-25 n. 3 (D.C.Cir.1997) (other citations omitted)).
In order for the Release to bar this action, it must both encompass Relator's qui tam
claims and the interest of enforcement must outweigh a public policy that would be
harmed by the enforcement. See El-Amin, 2007 WL 1302597, at *3; US. ex rel. Ritchie v.
Lockheed Martin Corp., 558 F.3d 1161, 1167-72 (10th Cir. 2009). The Release is
unenforceable if "the interest in its enforcement is outweighed in the circumstances by a
public policy harmed by the enforcement of the agreement." Town of Newton v. Rumery,
480 U.S. 386, 392 (1987). Here, the Release is indeed unenforceable because it violates
key public policy underpinnings of the False Claims Act.
When considering the enforceability of releases executed prior to the filing of an FCA
suit, courts have widely applied the analytical framework established by the Ninth Circuit
in United States ex rel. Green v. Northrop Corp., 59 F.3d 953 (9th Cir. 1995) and United
States ex rel. Hall v. Teledyne Wah Chang Albany, 104 F.3d 230 (9th Cir. 1997). See
United States ex rel. Radcliffe v. Purdue Pharma L.P., 600 F.3d 319, 329-30 (4th Cir.
2010); e.g., El-Amin, 2007 WL 1302597, at *2-6; Ritchie, 558 F.3d at 1169; United
States ex rel. Ladas v. Exelis, Inc., 824 F.3d 16 (2nd Cir. 2016). The Ninth Circuit in
Green and Hall addressed the enforceability of releases entered into before qui tam
claims are filed and focused on the Government's knowledge of the relator's fraud
allegations prior to the suit. See Green, 59 F.3d at 963-70; Hall, 104 F.3d at 232-34; see
also Purdue 600 F.3d at 332; Ritchie, 558 F.3d at 1170. In Green, the Ninth Circuit
7
considered whether a release of a qui tam claim is actionable if the release was entered
into without the Government's knowledge or consent and prior to the filing of the action.
Green, 59 F.3d at 956. It concluded that the release would be unenforceable because
enforcing the release would "impair a substantial public interest" by nullifying the
incentives the FCA gives to file qui tam claims. Id. at 963.
Then in Hall, the Ninth Circuit enforced a pre-filing release in a situation where the
Government was "aware of [the relator's] allegations regarding false certification" and
had the opportunity to investigate the charges prior to the release. Hall, 104 F.3d at 231-
33. The Ninth Circuit in Hall concluded in that circumstance, "the public interest in
having information brought forward that the [G]overnment could not otherwise obtain
[was] not implicated." Id. at 233. Therefore, "[w]hen the [G]ovemment is unaware of
potential FCA claims the public interest favoring the use of qui tam suits to supplement
federal enforcement weighs against enforcing prefiling releases. But when the
[G]ovemment is aware of the claims, prior to suit having been filed, public policies
supporting the private settlement of suits heavily favor enforcement of a prefiling
release." Purdue, 600 F.3d at 332.
Applying the above articulated framework to the present case, the Release was
entered into on March 16, 2016, prior to the November 2017 filing of the Relator's
complaint and prior to the Government having knowledge of the charges. The Defendant
Physicians argue that the Government had knowledge of the allegations because the
Govermnent had already intervened in United States ex rel. Haplin v. Kindred
8
Healthcare, Inc., No. 1:11-CV-12139-RGS (D.Mass. filed Dec. 7, 2011) (the "Halpin
Action"). See Def. Physicians' MTD at 16-17; SNFs' MTD at 38-42. However, the
Halpin Action only involved allegations of therapy upcoding against RehabCare (also
known as Kindred Healthcare, Inc.), did not involve any of the six Defendant Physicians,
and the allegations in the Halpin Action were distinct from the remuneration allegations
Relator Winnon alleged against the Defendant Physicians. See Complaint, Halpin Action.
Therefore, the alleged fraud committed by the six Defendant Physicians was not
"sufficiently disclosed to the [G]overnment," Purdue, 600 F.3d at 332, nor did the
Government have sufficient opportunity to conduct an investigation and "evaluate the
merits of the suit" against the six Defendant Physicians, El-Amin, 2007 WL 1302597, at
*7. The heightened pleading standard of Rule 9(b) also generally applies to state law
fraud claims brought in federal court. See Lawton ex rel. United States v. Takeda
Pharmaceutical Company, LTD, 842 F.3d 125, 132 (1 st Cir. 2016); United States ex rel.
Foster v. Bristol-Myers Squibb Co., 587 F.Supp.2d 805, 827 (E.D. Tex. 2008) (finding
that relator's state FCA claims, including the TMFPL, were also subject to the pleading
requirements ofRule 9(b)).
As a result, the interests in enforcing the Release are "outweighed in the
circumstances by a public policy harmed by the enforcement of the agreement." Rumery,
480 U.S. at 392. The public policy considerations at issue in this case are similar to those
Judge Penn analyzed in El-Amin. El-Amin, 2007 WL 1302597, at *6. First, the Court in
El-Amin noted that the FCA "provides that a qui tam complaint can be voluntarily
9
dismissed only if the court and the Attorney General give written consent to the dismissal
and their reasons for consenting." Id. (quotations omitted) (citing 31 U.S.C. § 3730(b)(l);
see also Gov't Notice to Decline Intervention at 2. Enforcing the release, which was
entered into prior to the Government's knowledge about the Defendant Physicians'
alleged misconduct, would "effectively sanction settlements without the [G]overnment's
consent" and may "encourage relators to settle claims without the [G]overnment's
knowledge." El-Amin, 2007 WL 1302597, at *6. Additionally, "[e]nforcing a release
entered into before the [G]overnment decides to intervene would frustrate the financial
incentives designed to encourage relator participation" and could "hinder the
government's ability to investigate the matter." Id. at *7. 10 As such, the Release here does
not bar Relator's claims or deprive this Court of jurisdiction to hear them. 11
a. Particularity of Fraud Claims
Defendant Physicians argue that Relator failed to plead fraud with particularity to the
standard required by Federal Rule of Civil Procedure 9(b) and contend that the illegal
remunerations received by the Defendant Physicians are only implied in invoices and
accounting records. Def. Physicians' MTD at 12-15. The Relator maintains that she did
adequately plead that the Defendant Physicians participated in an unlawful kickback
scheme. Relator's Resp. to Def. Physician's MTD at 4-9. Unfortunately for the Relator,
10
The Government's ultimate decision not to intervene in the case after investigation, see Gov't Notice to Decline
Intervention, does not dilute or diminish the public policy concerns at issue. The public policy considerations noted
above and discussed in El-Amin are predicated on the importance of the Government's abilities to learn about the
allegations and investigate the matter, which would be frustrated by the enforcement of such a release, regardless of
whether or not the Government ultimately decides to intervene.
11
The Court does not need to reach the issue of whether the release encompasses Relator's claims.
10
however, the Defendant Physicians have the better argument, and the Court finds that the
Relator failed to plead fraud with sufficient particularity. How so?
Rule 9(b) requires Relator to "state with particularity the circumstances constituting
fraud." Fed. R. Civ. P. 9(b). The heightened pleading standard serves to "discourage[] the
initiation of suits brought solely for their nuisance value, and safeguards potential
defendants from frivolous accusations of moral turpitude" and to "guarantee all
defendants sufficient information to allow for preparation of a response." United States
ex rel. Heath v. AT&T, Inc., 791 F.3d 112, 123 (D.C. Cir. 2015). Moreover, the False
Claims Act is "self-evidently an anti-fraud statute, [and] complaints brought under it
must comply with Rule 9(b)." United States ex rel. Totten v. Bombardier Corp., 286 F.3d
542, 551-52 (D.C. Cir. 2002).
Rule 9(b) does not require a complaint "to contain a detailed allegation of all facts
supporting each and every instance of submission of a false claim," United States ex rel.
Barrett v. Columbia/HCA Healthcare Corp., 251 F. Supp. 2d 28, 35 (D.D.C. 2003), but
in order to satisfy Rule 9(b ), a plaintiff must allege the "who," "what," "when," and
"where" with respect to the circumstances of an alleged fraud. See United States ex rel.
Riedel v. Boston Heart Diagnostics Corporation, 332 F.Supp.3d 48, 76 (D.D.C. 2018)
(citing Heath, 791 F.3d at 124).
Relator Winnon's allegations against the six Defendant Physicians here are
insufficient to satisfy Rule 9(b)' s particularity standards. Relator contends that the six
Defendant Physicians illegally referred patients to the Defendant Facilities in exchange
11
for "sham" medical directorships and other remunerations from Empire Spanish
Meadows in the form of meals, alcohol, and other gifts. See SAC at ,r,r 93-118. According
to the Relator, she does not recall ever seeing a written agreement between the facilities
and a "medical director" and the medical directors were paid a static monthly rate. Id. at
,r,r 98-99. The Relator alleges such a static payment rate from month-to-month is
suspicious because it doesn't account for the amount of work the physicians worked in a
particular month. Id. The Relator also alleges that Empire Spanish Meadows, one of the
Defendant Facilities, provided remunerations (in the form of alcohol, meals, etc.) to
discharge planners and doctors, including the six Defendant Physicians, as evidenced by
examples from Empire Spanish Meadows' own account records from 2013 to 2015. Id. at
,r,r 109-10.
Although Relator adequately alleges the "who," "where," and "when" requirements of
Rule 9(b) by identifying the individuals and corporate entities who allegedly participated
in the purported schemes, 12 the locations at which the scheme allegedly occurred, 13 and
the relevant time period, 14 the "what" element is not alleged sufficiently because she fails
to provide a "detailed identification" of the allegedly fraudulent scheme. See Riedel, 332
F.Supp.3d at 78. Instead, a careful reading of the SAC reveals only conclusory
allegations of the alleged kickback scheme to provide unlawful remunerations and
kickbacks to the six Defendant Physicians in return for unlawful referrals. SAC at ,r,r 93-
12
See SAC at ,i,i 8-11.
13
Id. at iliJ 3, 97-109 .
14
Id. at iJ 3.
12
118. Although Rule 9(b) does not require the Relator to "identify particular claims
resulting from the kickback scheme," Relator fails to "fully explain how the alleged
scheme concerning these physicians is supposed to work." United States ex rel. Parikh v.
Citizens Med. Ctr., 977 F. Supp. 2d 654, 665, 674-75 (S.D. Tex. 2013).
Unlike in United States ex rel. Thomas v. St. Joseph Hospice, LLC, No. 16-CV-143-
KS-MTP, 2019 WL 1271019 (S.D. Miss. 2019), a case involving similar allegations of
allegedly fraudulent medical directorships, Relator Winnon did not plead "substantial
details of the alleged agreement." In Thomas, the Relators made the following specific
allegations of the defendants, providers of hospice services: defendants paid their medical
directors varying rates based on the volume and value of each physician's referrals;
defendants' employees made up fake time entries and compensation sheets that didn't
correspond to the actual amount of time the medical directors worked; defendants
reduced a medical director's pay when the medical director stopped bringing in referrals;
and relators identified specific patients referred to the defendants by specific medical
directors in exchange for remuneration as well as the specific dates the patients were
admitted. Id. at 10. Not surprisingly, the court in Thomas held that such allegations are
"reliable indications of fraud" and the relators had pleaded "a level of detail that
demonstrates that an alleged scheme likely resulted in bills submitted for government
payment." Id. (quoting United States ex rel. Nunnally v. West Calcasieu Cameron Hosp.,
519 Fed.Appx. 890, 893 (5th Cir. 2013)). In the instant case, Relator Winnon's
allegations fall far short of the level of specificity pleaded by the relator in Thomas.
13
Relator Winnon's allegations are also unlike the plaintiffs' allegations in United
States ex rel. Kaczmarcyk v. SCCI Health Services Corp., No. H-99-1031, 2004 WL
7089810, at *4 (S.D. Tex. March 11, 2004). Although the defendant, a hospital, alleged
that the United States' complaint failed to meet Rule 9(b) requirements, the court in
Kaczmarcyk found that the United States' complaint provided sufficient detail of the
alleged scheme. Id. at *4-7. In that case, the complaint alleged that the medical
directorship agreements were shams because the compensation provided was "in reality,
both a reward for the volume of past referrals and an incentive to continue a high number
of referrals" and explained that three of the physicians hired as medical directors
admitted nearly fifty percent of the defendant hospital's patients during a certain time
period. Id. at *4-5. The court noted that the Government's complaint also explained why
the medical directorships didn't fit within the personal service arrangement exception
since the defendant hired more medical directors than was reasonable and necessary,
compensated the medical directors at a rate exceeding fair market value for the services
they were expected to perform, and took into account past and future referrals in setting
the rates. Id. at *5. By comparison, Relator Winnon's allegations provide far less detail
about the alleged scheme involving the six Defendant Physicians' medical directorships.
Rather, Relator Winnon's allegations are more akin to the original complaint
dismissed by the court in United States ex rel. Emanuele v. Medicor Associates, No. 10-
245 Erie, 2013 WL 3893323, at *8 (W.D. Pa. July 26, 2013). In Emanuele, the court
found that the relator's original complaint had failed to meet the pleading requirement
14
because it "[ did] not delineate why the medical directorships at issue were not legitimate
service contracts, what instructions concerning the service contracts were allegedly given,
and whether any specific or even general number of referrals allegedly took place
pursuant to the contracts." Id. Ultimately, the court in Emanuele held that the allegations
contained in the original complaint were "conclusory and nonspecific" and dismissed the
claims. Id.Relator Winnon's claims against the six Defendant Physicians here fail to provide the
types of "detailed identification" of the allegedly fraudulent scheme, Riedel, 332
F. Supp. 3d at 78, which "fully explain[s] how the alleged scheme concerning these
physicians is supposed to work," Parikh, 977 F. Supp. at 674-75, as is required by Rule
9(b). Indeed, Relator's failure to plead fraud with sufficient particularity is especially
stark as it relates to defendants Dr. Carubba and Dr. Factoriza who relator does not even
contend were paid medical directors of Spanish Meadows.
Ill. CONCLUSION
As such, for all of the foregoing reasons, the Defendant Physicians' Motion to
Dismiss must be and is hereby GRANTED.
RICHA'·R£irioN
United States District Judge
15